Edap Tms (NASDAQ:EDAP) Rating Lowered to Sell at StockNews.com

StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research note issued to investors on Friday.

Separately, HC Wainwright increased their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the stock a buy rating in a report on Monday, April 1st.

Edap Tms Trading Down 0.8 %

Shares of EDAP stock opened at $7.08 on Friday. The firm has a market cap of $262.67 million, a P/E ratio of -11.24 and a beta of 0.65. Edap Tms has a 1-year low of $3.60 and a 1-year high of $12.09. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.84 and a quick ratio of 2.30. The firm’s 50-day simple moving average is $7.37 and its 200-day simple moving average is $6.30.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.13). The company had revenue of $21.27 million for the quarter, compared to analysts’ expectations of $21.30 million. Edap Tms had a negative return on equity of 34.33% and a negative net margin of 35.03%. As a group, equities analysts forecast that Edap Tms will post -0.36 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Rock Springs Capital Management LP grew its position in Edap Tms by 14.6% in the third quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after acquiring an additional 173,700 shares in the last quarter. Miracle Mile Advisors LLC acquired a new stake in Edap Tms in the first quarter valued at approximately $136,000. Summit Trail Advisors LLC acquired a new stake in Edap Tms in the third quarter valued at approximately $77,000. Finally, Milestone Investment Advisors LLC acquired a new stake in shares of Edap Tms during the third quarter worth approximately $39,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.